Increasing Access to Medications and Devices for the Care of Low‐Risk Childbearing Families: An Analysis of Existing Law and Strategies for Advocacy. (26th August 2021)

• Record Type: Journal Article
• Authors: Effland, Kristin J.; Hays, Karen; Zell, Britney A.; Lawal, Tara K.; Grantham, Rhonda L.; Koontz, Megan
• Is Part Of: Journal of midwifery & women's health. Volume 66:Number 5(2021)
• Page Start: 604
• Page End: 623
• Publication Date: 2021-08-26
• Subjects: contraception/family planning -- health policy -- home birth -- birth centers -- midwifery professional issues -- pharmacology -- quality improvement -- vulnerable populations; Midwives -- Periodicals; Obstetrics -- Periodicals; Women's health services -- Periodicals; 618.2
• DOI: 10.1111/jmwh.13275
• Languages: English
• ISSNs: 1526-9523

Abstract

Abstract: Limited access to medications and devices relevant to the care of low‐risk childbearing families acts as a barrier to the successful integration of high‐quality midwifery care into health care systems. Families who live in clinically underserved areas, whether urban or rural, are particularly in need of perinatal professionals who can provide comprehensive care. This article reviews existing US laws that impact whether families who choose community‐based care with direct entry midwives have access, through their chosen provider, to the medications and devices relevant to their normal perinatal and postpartum care. Scope of practice and practice authority are considered as they relate to access to medications and devices primarily for certified professional midwives and state‐licensed midwives. These professionals are the primary health care providers offering community‐based care and birth at home and in freestanding birth centers. Washington state laws are compared and contrasted with laws from other states and jurisdictions, with the aim of identifying ways to improve service delivery for families who choose community‐based midwifery care. Recent and historical efforts to expand Washington state's midwifery drugs and devices formulary are described. This discussion outlines the Washington context for direct entry community midwifery practice, highlights relevant legal examples, and describes current and future efforts around quality improvement. Information from a midwifery clinic serving some of Washington's most vulnerable pregnant and postpartum families allows for an exploration of the role that access to essential medications and devices might play in supporting midwives to address health inequities. Ideal statutory and regulatory language, lessons learned from an analysis of Washington's experience, and strategies to overcome barriers are described to aid and inspire midwifery advocates in other jurisdictions who want to increase access and enhance their ability to offer current evidence‐based care. Policy makers can improve health, health equity, consumer choice, and access to evidence‐based care by using ideal legal language for midwifery practice authority.